Phycoremediation integrated approach for the removal of pharmaceuticals and personal care products from wastewater - A review.

Pharmaceuticals and personal care products (PPCPs) are of emerging concerns because of their large usage, persistent nature which promised their continuous disposal into the environment, as these pollutants are stable enough to pass through wastewater treatment plants causing hazardous effects on all the organisms through bioaccumulation, biomagnification, and bioconcentration. The available technologies are not capable of eliminating all the PPCPs along with their degraded products but phycoremediation has the advantage over these technologies by biodegrading the pollutants without developing resistant genes. Even though phycoremediation has many advantages, industries have found difficulty in adapting this technology as a single-stage treatment process. To overcome these drawbacks recent research studies have focused on developing technology that integrated phycoremediation with the commonly employed treatment processes that are in operation for treating the PPCPs effectively. This review paper focuses on such research approaches that focused on integrating phycoremediation with other technologies such as activated sludge process (ASP), advanced oxidation process (AOP), Up-flow anaerobic sludge blanket reactor (UASBR), UV irradiation, and constructed wetland (CW) with the advantages and limitations of each integration processes. Furthermore, augmenting phycoremediation by co-metabolic mechanism with the addition of sodium chloride, sodium acetate, and glucose for the removal of PPCPs has been highlighted in this review paper.

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.